Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CBO Holds Line On Comparative Effectiveness’ Lack Of Initial Savings

Executive Summary

The Congressional Budget Office reiterated its stance in a new scoring that government funding for comparative effectiveness research will be slow to yield significant savings and, for the first 10 years, it will only increase the federal deficit

You may also be interested in...



Comparative Effectiveness Survives In Stimulus Package, Debate Over Language Continues

Conferee report language circulating reveals intent to use research strictly for clinical comparisons, but legislative language remains under debate.

Comparative Effectiveness Survives In Stimulus Package, Debate Over Language Continues

Conferee report language circulating reveals intent to use research strictly for clinical comparisons, but legislative language remains under debate.

Comparative Effectiveness Bill Calls For Private Group To Plan Research

While getting little exposure in the new Medicare law, comparative effectiveness research is getting full attention in a bill introduced by Sen. Max Baucus, D-Mont., that offers a comprehensive roadmap toward conducting the research and disseminating findings

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS050493

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel